Artificial intelligence-enabled detection and assessment of Parkinson’s disease
www.BeGenomics.com
Reference: Yang, Y et al Nature Medicine (2022)
BeGenomics.com
PD is the fastest-growing neurological disease in the world. Over 1 million people in the US are living with PD as of 2020, resulting in an economic burden of $52 billion per year.
BeGenomics.com
A key difficulty in PD drug development and disease management is the lack of effective diagnostic biomarkers.
BeGenomics.com
Scientists developed an artificial intelligence (AI) model to detect PD and track its progression from nocturnal breathing signals.
BeGenomics.com
The model was evaluated on a large dataset comprising 7,671 individuals, using data from several hospitals in the United States, as well as multiple public datasets.
BeGenomics.com
The model can assess PD in the home setting in a touchless manner, by extracting breathing from radio waves that bounce off a person’s body during sleep.
BeGenomics.com
They evaluated the accuracy of diagnosing PD from one night of nocturnal breathing. The AI model detects PD with high accuracy.
BeGenomics.com
They further investigated whether the accuracy improves by combining several nights from the same individual.
BeGenomics.com
They validated their AI model on an external testset (n = 1,920 nights from 1,920 subjects out of which 644 have PD) from an independent hospital not involved during model development.
BeGenomics.com
They evaluate the ability of their model to produce a PD severity score that correlates well with the MDS-UPDRS by analyzing the patients’ nocturnal breathing.
For details click here
BeGenomics.com
Artificial intelligence-enabled detection and assessment of Parkinson’s disease
BeGenomics.com
Artificial intelligence-enabled detection and assessment of Parkinson’s disease
BeGenomics.com
Artificial intelligence-enabled detection and assessment of Parkinson’s disease
BeGenomics.com
Artificial intelligence-enabled detection and assessment of Parkinson’s disease